Cross-regulation between Notch signaling pathway and miRNA machinery in cancer.

[1]  Ansar Karimian,et al.  The importance of miRNAs and epigenetics in acute lymphoblastic leukemia prognosis , 2018, Journal of cellular physiology.

[2]  M. de la Guardia,et al.  Modulating tumor hypoxia by nanomedicine for effective cancer therapy , 2018, Journal of cellular physiology.

[3]  Ansar Karimian,et al.  Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin. , 2018, Gene.

[4]  B. Baradaran,et al.  Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[5]  R. Reiter,et al.  Melatonin: A pleiotropic molecule that modulates DNA damage response and repair pathways , 2017, Journal of pineal research.

[6]  Xu Cao,et al.  MiR-497∼195 cluster regulates angiogenesis during coupling with osteogenesis by maintaining endothelial Notch and HIF-1α activity , 2017, Nature Communications.

[7]  S. Shen,et al.  MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling , 2017, Oncology letters.

[8]  S. Jackson,et al.  ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response. , 2017, Molecular cell.

[9]  B. Yousefi,et al.  DNA repair and damage pathways in breast cancer development and therapy. , 2017, DNA repair.

[10]  Xianfeng Gao,et al.  MicroRNA-141 inhibits the self-renewal of glioblastoma stem cells via Jagged1 , 2017, Molecular medicine reports.

[11]  Donglin Wang,et al.  Sensitivity of non-small cell lung cancer to erlotinib is regulated by the Notch/miR-223/FBXW7 pathway , 2017, Bioscience reports.

[12]  Hongyan Yuan,et al.  miR-130b-3p inhibits cell invasion and migration by targeting the Notch ligand Delta-like 1 in breast carcinoma. , 2017, Gene.

[13]  S. Taraviras,et al.  Mismatch repair regulates Cdt1 after UV damage , 2017, Cell cycle.

[14]  B. Yousefi,et al.  The crosstalk between Wnt/β-catenin signaling pathway with DNA damage response and oxidative stress: Implications in cancer therapy. , 2017, DNA repair.

[15]  B. Yousefi,et al.  Breast tumor stroma: A driving force in the development of resistance to therapies , 2017, Chemical biology & drug design.

[16]  Yan Zhou,et al.  miR424‐5p functions as an anti‐oncogene in cervical cancer cell growth by targeting KDM5B via the Notch signaling pathway , 2017, Life sciences.

[17]  Yan Tang,et al.  miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial–mesenchymal transition and the Notch signaling pathway , 2017, Scientific Reports.

[18]  R. Alani,et al.  Notch3 Signaling-Mediated Melanoma-Endothelial Crosstalk Regulates Melanoma Stem-Like Cell Homeostasis and Niche Morphogenesis , 2016, Laboratory investigation; a journal of technical methods and pathology.

[19]  Nosratollah Zarghami,et al.  Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge. , 2016, Anti-cancer agents in medicinal chemistry.

[20]  Gang Wu,et al.  miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma , 2016, Journal of Biomedical Science.

[21]  B. Yousefi,et al.  DNA damage response regulation by microRNAs as a therapeutic target in cancer. , 2016, DNA repair.

[22]  Jianwen Liu,et al.  MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells , 2016, Oncotarget.

[23]  E. Alizadeh,et al.  Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment , 2016, Drug Research.

[24]  M. Rahmati-Yamchi,et al.  Co-inhibition of Notch and NF-κB Signaling Pathway Decreases Proliferation through Downregulating IκB-α and Hes-1 Expression in Human Ovarian Cancer OVCAR-3 Cells , 2016, Drug Research.

[25]  B. Lei,et al.  MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1 , 2016, Oncology reports.

[26]  F. d’Adda di Fagagna,et al.  NOTCH1 Inhibits Activation of ATM by Impairing the Formation of an ATM-FOXO3a-KAT5/Tip60 Complex , 2016, Cell reports.

[27]  B. Niang,et al.  Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family , 2016, International journal of molecular medicine.

[28]  K. Song,et al.  Abstract 949: Epigenetic silencing of microRNA-34a promotes cholangiocarcinoma growth by regulating Notch pathway , 2016 .

[29]  Yuan Yin,et al.  miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1. , 2016, Pathology, research and practice.

[30]  G. Dotto,et al.  Negative control of CSL gene transcription by stress/DNA damage response and p53 , 2016, Cell cycle.

[31]  H. Feilotter,et al.  Roles for miR-375 in Neuroendocrine Differentiation and Tumor Suppression via Notch Pathway Suppression in Merkel Cell Carcinoma. , 2016, The American journal of pathology.

[32]  Li Wang,et al.  miR‐342‐5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling , 2016, Journal of the American Heart Association.

[33]  Beiyan Zhou,et al.  MiR-129 triggers autophagic flux by regulating a novel Notch-1/ E2F7/Beclin-1 axis to impair the viability of human malignant glioma cells , 2016, Oncotarget.

[34]  B. Baradaran,et al.  Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. , 2015, Cellular and molecular biology.

[35]  Y. Li,et al.  Pro‑angiogenic microRNA‑296 upregulates vascular endothelial growth factor and downregulates Notch1 following cerebral ischemic injury. , 2015, Molecular medicine reports.

[36]  Shiying Yu,et al.  Notch signaling: an emerging therapeutic target for cancer treatment. , 2015, Cancer letters.

[37]  M. O’Connor,et al.  Targeting the DNA Damage Response in Cancer. , 2015, Molecular cell.

[38]  Ming Liu,et al.  MicroRNA-375 overexpression influences P19 cell proliferation, apoptosis and differentiation through the Notch signaling pathway , 2015, International journal of molecular medicine.

[39]  He-da Zhang,et al.  Luteolin Inhibits Breast Cancer Development and Progression In Vitro and In Vivo by Suppressing Notch Signaling and Regulating MiRNAs , 2015, Cellular Physiology and Biochemistry.

[40]  P. Townsend,et al.  The DNA damage response and immune signaling alliance: Is it good or bad? Nature decides when and where. , 2015, Pharmacology & therapeutics.

[41]  Xiaobo Zhang,et al.  The role of miR-100-mediated Notch pathway in apoptosis of gastric tumor cells. , 2015, Cellular signalling.

[42]  Lianhong Li,et al.  MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway , 2015, Cancer science.

[43]  M. Nourani,et al.  Overexpression of Metastatic Related MicroRNAs, Mir-335 and Mir-10b, by Staphylococcal Enterotoxin B in the Metastatic Breast Cancer Cell Line. , 2015, Advanced pharmaceutical bulletin.

[44]  Chin-Wen Chi,et al.  The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis , 2015, Oncotarget.

[45]  S. Bicciato,et al.  Notch is a direct negative regulator of the DNA-damage response , 2015, Nature Structural &Molecular Biology.

[46]  Bo Xu,et al.  Characterization of microRNA profile in human cumulus granulosa cells: Identification of microRNAs that regulate Notch signaling and are associated with PCOS , 2015, Molecular and Cellular Endocrinology.

[47]  Jian Wu,et al.  MicroRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer. , 2015, Oncology reports.

[48]  Frances M. G. Pearl,et al.  Therapeutic opportunities within the DNA damage response , 2015, Nature Reviews Cancer.

[49]  J. Kitajewski,et al.  NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth. , 2015, Cancer discovery.

[50]  E. Feldman,et al.  Notch Signaling Regulates Motor Neuron Differentiation of Human Embryonic Stem Cells , 2015, Stem cells.

[51]  I. Paterson,et al.  The opposing roles of NOTCH signalling in head and neck cancer: a mini review. , 2015, Oral diseases.

[52]  Yongyi Huang,et al.  MicroRNA‐134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins , 2015, FEBS letters.

[53]  M. Kastan,et al.  The DNA damage response: implications for tumor responses to radiation and chemotherapy. , 2015, Annual review of medicine.

[54]  E. Song,et al.  Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance. , 2014, Cancer research.

[55]  B. Baradaran,et al.  Growth-Inhibitory and Apoptosis-Inducing Effects of Punica granatum L. var. spinosa (Apple Punice) on Fibrosarcoma Cell Lines. , 2014, Advanced pharmaceutical bulletin.

[56]  Anil K Sood,et al.  Molecular Pathways: Translational and Therapeutic Implications of the Notch Signaling Pathway in Cancer , 2014, Clinical Cancer Research.

[57]  Jianhua Wang,et al.  Targeting the Notch signaling pathway in cancer therapeutics , 2014, Thoracic cancer.

[58]  R. Aguiar,et al.  A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B and T cell malignancies , 2014, Leukemia.

[59]  R. McLendon,et al.  miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways. , 2014, The Journal of clinical investigation.

[60]  Hao Li,et al.  MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells , 2014, Tumor Biology.

[61]  Yuan Yin,et al.  MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1 , 2014, Protein & Cell.

[62]  B. Baradaran,et al.  RNA interference and its role in cancer therapy. , 2014, Advanced pharmaceutical bulletin.

[63]  D. Chen,et al.  Notch-dependent repression of miR-155 in the bone marrow niche regulates hematopoiesis in an NF-κB-dependent manner. , 2014, Cell stem cell.

[64]  Myung Ah Lee,et al.  275: MiR-136 targeting Notch3 is involved in chemoresistance and angiogenesis in ovarian cancer cells , 2014 .

[65]  Li-Ming Zhou,et al.  Correlation of over-expressions of miR-21 and Notch-1 in human colorectal cancer with clinical stages. , 2014, Life sciences.

[66]  Jun Yu,et al.  microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer , 2014, Molecular Cancer.

[67]  A Gulino,et al.  Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia , 2014, Leukemia.

[68]  Z. Faghfoori,et al.  Serum Arsenic and Lipid Peroxidation Levels in Patients with Multiple Sclerosis , 2014, Biological Trace Element Research.

[69]  O. Klein,et al.  Crosstalk between miR-34a and Notch Signaling Promotes Differentiation in Apical Papilla Stem Cells (SCAPs) , 2014, Journal of dental research.

[70]  Michael R Green,et al.  miR-146a promotes the initiation and progression of melanoma by activating Notch signaling , 2014, eLife.

[71]  B. Baradaran,et al.  Reduced ABCB1 Expression and Activity in the Presence of Acrylic Copolymers. , 2014, Advanced pharmaceutical bulletin.

[72]  R. Muschel,et al.  Targeting ATR in DNA damage response and cancer therapeutics. , 2014, Cancer treatment reviews.

[73]  D. Chan,et al.  Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer , 2013, Oncotarget.

[74]  L. Miele,et al.  Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells. , 2013, Cancer letters.

[75]  Y. Kawasaki,et al.  The miR-1-NOTCH3-Asef Pathway Is Important for Colorectal Tumor Cell Migration , 2013, PloS one.

[76]  Hyun-Sook Kim,et al.  MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma. , 2013, Human pathology.

[77]  K. Seong,et al.  Rhamnetin and Cirsiliol Induce Radiosensitization and Inhibition of Epithelial-Mesenchymal Transition (EMT) by miR-34a-mediated Suppression of Notch-1 Expression in Non-small Cell Lung Cancer Cell Lines* , 2013, The Journal of Biological Chemistry.

[78]  Jingru Zhang,et al.  Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling. , 2013, Carcinogenesis.

[79]  Xiling Shen,et al.  A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. , 2013, Cell stem cell.

[80]  I. Screpanti,et al.  γ‐Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down‐regulation , 2013, International journal of cancer.

[81]  Aamir Ahmad,et al.  Novel strategies targeting cancer stem cells through phytochemicals and their analogs , 2013, Drug Delivery and Translational Research.

[82]  Sheng-hua Zhou,et al.  Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival. , 2013, International journal of molecular medicine.

[83]  P. Li,et al.  MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression , 2013, Journal of Neuro-Oncology.

[84]  S. Henderson,et al.  The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. , 2012, Blood.

[85]  Zhiwei Wang,et al.  Delta‐tocotrienol suppresses Notch‐1 pathway by upregulating miR‐34a in nonsmall cell lung cancer cells , 2012, International journal of cancer.

[86]  S. Zhong,et al.  MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1. , 2012, Archives of medical research.

[87]  X. Niu,et al.  miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia , 2012, Molecular and Cellular Biochemistry.

[88]  Q. Ning,et al.  MicroRNA-34a inhibits human brain glioma cell growth by down-regulation of notch1 , 2012, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[89]  Hong-zhao Li,et al.  Inhibitory effects of microRNA-34a on cell migration and invasion of invasive urothelial bladder carcinoma by targeting notch1 , 2012, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[90]  B. Baradaran,et al.  Inhibition of MEK/ERK1/2 Signaling Affects the Fatty Acid Composition of HepG2 Human Hepatic Cell Line. , 2012, BioImpacts : BI.

[91]  B. Dawson,et al.  miRNA-34c regulates Notch signaling during bone development. , 2012, Human molecular genetics.

[92]  Zhao-Jun Liu,et al.  The Role of MicroRNAs in Mediating the Oncogenic Effect of Notch Signaling in Melanoma , 2012 .

[93]  A. Weng,et al.  Notch Signaling Represses Mir-223 in T-Cell Acute Lymphoblastic Leukemia , 2011 .

[94]  A. Rangarajan,et al.  A Monoclonal Antibody against Human Notch1 Ligand–Binding Domain Depletes Subpopulation of Putative Breast Cancer Stem–like Cells , 2011, Molecular Cancer Therapeutics.

[95]  Iannis Aifantis,et al.  Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think , 2011, The Journal of experimental medicine.

[96]  P. Pantazis,et al.  Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism , 2011, Journal of nanobiotechnology.

[97]  Giuseppe Basso,et al.  MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma , 2011, PloS one.

[98]  Mingli Liu,et al.  Role of Notch and its oncogenic signaling crosstalk in breast cancer. , 2011, Biochimica et biophysica acta.

[99]  G. Goodall,et al.  The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. , 2011, The Journal of clinical investigation.

[100]  Meng Li,et al.  MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways , 2011, Oncogene.

[101]  Simone Brabletz,et al.  The ZEB1/miR‐200 feedback loop controls Notch signalling in cancer cells , 2011, The EMBO journal.

[102]  Diana M Vallejo,et al.  Targeting Notch signalling by the conserved miR-8/200 microRNA family in development and cancer cells , 2011, The EMBO journal.

[103]  Zhiwei Wang,et al.  Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. , 2010, Cancer Letters.

[104]  Kai-Fai Lee,et al.  MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. , 2010, Carcinogenesis.

[105]  Patrick J. Paddison,et al.  Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia , 2010, Nature Cell Biology.

[106]  Yunqing Li,et al.  The Neuronal MicroRNA miR-326 Acts in a Feedback Loop with Notch and Has Therapeutic Potential against Brain Tumors , 2009, The Journal of Neuroscience.

[107]  J. Bartek,et al.  The DNA-damage response in human biology and disease , 2009, Nature.

[108]  Yunqing Li,et al.  MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. , 2009, Cancer research.

[109]  Xudong Dai,et al.  Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells. , 2009, Cancer research.

[110]  F. Oswald,et al.  The Notch signaling pathway: Transcriptional regulation at Notch target genes , 2009, Cellular and Molecular Life Sciences.

[111]  Li-Xuan Qin,et al.  gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. , 2009, Cancer research.

[112]  W. Dalton,et al.  Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. , 2008, Blood.

[113]  George P Cobb,et al.  microRNAs as oncogenes and tumor suppressors. , 2007, Developmental biology.

[114]  Stefano Volinia,et al.  MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[115]  Xuetao Cao,et al.  Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. , 2003, Cancer research.

[116]  M. Baron,et al.  An overview of the Notch signalling pathway. , 2003, Seminars in cell & developmental biology.

[117]  Long-Bang Chen,et al.  Notch-1 Confers Chemoresistance in Lung Adenocarcinoma to Taxanes through AP-1/microRNA-451 Mediated Regulation of MDR-1. , 2016, Molecular therapy. Nucleic acids.

[118]  G. Peng,et al.  Non-coding RNAs: an emerging player in DNA damage response. , 2015, Mutation research. Reviews in mutation research.

[119]  J. Taub,et al.  New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia. , 2014, Cellular signalling.

[120]  B. Issac,et al.  Lost miRNA surveillance of Notch, IGFR pathway—road to sarcomagenesis , 2013, Tumor Biology.

[121]  Maria A. Kashat,et al.  Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness. , 2012, American journal of translational research.